Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
DRP-104 is a prodrug of DON that is currently undergoing clinical trials (NCT04471415)
Sockalingam stressed that, as treatments become more accessible, other supports must be strengthened in concert, noting that risks associated with obesity medications include eating disorders and mental-health problems.
Over the past few years, several effective anti-obesity medications have been introduced, particularly for people who fail to lose weight with conservative measures alone
Weight Loss Goal 10-20 pounds 20+ pounds Results May Vary Keep in mind that individual responses to these medications may vary, and weight loss outcomes may depend on various factors such as diet, exercise, and baseline metabolic health
US$ 25.33
US$ 27.81
US$ 21.60
